Cargando…

Contraception During Perimenopause: Practical Guidance

Climacteric is by no means in itself a contraindication to safe contraception. On the contrary, there are several conditions related to the perimenopause that could benefit from the use of modern contraceptives, mainly hormonal, with the goals of avoiding unintended pregnancies and giving further po...

Descripción completa

Detalles Bibliográficos
Autores principales: Grandi, Giovanni, Di Vinci, Pierluigi, Sgandurra, Alice, Feliciello, Lia, Monari, Francesca, Facchinetti, Fabio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9296102/
https://www.ncbi.nlm.nih.gov/pubmed/35866143
http://dx.doi.org/10.2147/IJWH.S288070
_version_ 1784750193253548032
author Grandi, Giovanni
Di Vinci, Pierluigi
Sgandurra, Alice
Feliciello, Lia
Monari, Francesca
Facchinetti, Fabio
author_facet Grandi, Giovanni
Di Vinci, Pierluigi
Sgandurra, Alice
Feliciello, Lia
Monari, Francesca
Facchinetti, Fabio
author_sort Grandi, Giovanni
collection PubMed
description Climacteric is by no means in itself a contraindication to safe contraception. On the contrary, there are several conditions related to the perimenopause that could benefit from the use of modern contraceptives, mainly hormonal, with the goals of avoiding unintended pregnancies and giving further possible benefits beyond contraception (menstrual cycle control, a reduction of vasomotor symptoms and menstrual migraines, a protection against bone loss, a positive oncological risk/benefit balance). This narrative review aims to provide practical guidance on their possible use in this particular life stage, both short- and long-acting reversible contraceptives, and to assist clinicians for women transitioning from contraception to their menopausal years, including the possible initiation of postmenopausal hormone therapy. Comprehensive contraceptive counselling is an essential aspect of the overall health and wellbeing of women and should be addressed with each such patient irrespective of age.
format Online
Article
Text
id pubmed-9296102
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-92961022022-07-20 Contraception During Perimenopause: Practical Guidance Grandi, Giovanni Di Vinci, Pierluigi Sgandurra, Alice Feliciello, Lia Monari, Francesca Facchinetti, Fabio Int J Womens Health Review Climacteric is by no means in itself a contraindication to safe contraception. On the contrary, there are several conditions related to the perimenopause that could benefit from the use of modern contraceptives, mainly hormonal, with the goals of avoiding unintended pregnancies and giving further possible benefits beyond contraception (menstrual cycle control, a reduction of vasomotor symptoms and menstrual migraines, a protection against bone loss, a positive oncological risk/benefit balance). This narrative review aims to provide practical guidance on their possible use in this particular life stage, both short- and long-acting reversible contraceptives, and to assist clinicians for women transitioning from contraception to their menopausal years, including the possible initiation of postmenopausal hormone therapy. Comprehensive contraceptive counselling is an essential aspect of the overall health and wellbeing of women and should be addressed with each such patient irrespective of age. Dove 2022-07-15 /pmc/articles/PMC9296102/ /pubmed/35866143 http://dx.doi.org/10.2147/IJWH.S288070 Text en © 2022 Grandi et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Review
Grandi, Giovanni
Di Vinci, Pierluigi
Sgandurra, Alice
Feliciello, Lia
Monari, Francesca
Facchinetti, Fabio
Contraception During Perimenopause: Practical Guidance
title Contraception During Perimenopause: Practical Guidance
title_full Contraception During Perimenopause: Practical Guidance
title_fullStr Contraception During Perimenopause: Practical Guidance
title_full_unstemmed Contraception During Perimenopause: Practical Guidance
title_short Contraception During Perimenopause: Practical Guidance
title_sort contraception during perimenopause: practical guidance
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9296102/
https://www.ncbi.nlm.nih.gov/pubmed/35866143
http://dx.doi.org/10.2147/IJWH.S288070
work_keys_str_mv AT grandigiovanni contraceptionduringperimenopausepracticalguidance
AT divincipierluigi contraceptionduringperimenopausepracticalguidance
AT sgandurraalice contraceptionduringperimenopausepracticalguidance
AT feliciellolia contraceptionduringperimenopausepracticalguidance
AT monarifrancesca contraceptionduringperimenopausepracticalguidance
AT facchinettifabio contraceptionduringperimenopausepracticalguidance